Characterization of Patients with Chronic Obstructive Pulmonary Disease Initiating Single-Inhaler Long-Acting Muscarinic Antagonist/Long-Acting ß2-Agonist Dual Therapy in a Primary Care Setting in England.
Int J Chron Obstruct Pulmon Dis
; 17: 1781-1795, 2022.
Article
in En
| MEDLINE
| ID: mdl-35983168
Key words
Full text:
1
Database:
MEDLINE
Therapeutic Methods and Therapies TCIM:
Terapias_biologicas
/
Peloideterapia
Main subject:
Muscarinic Antagonists
/
Pulmonary Disease, Chronic Obstructive
Type of study:
Diagnostic_studies
/
Observational_studies
/
Risk_factors_studies
Language:
En
Journal:
Int J Chron Obstruct Pulmon Dis
Year:
2022
Type:
Article
Affiliation country:
United kingdom